TickerKhojEVONILE · Pharmaceuticals
Evonile Pharma Limited
- Company snapshot
- 2026-11-05
- Latest available quarter
- Not suppliedReporting basis not supplied
- Ownership quarter
- Not supplied
COMPANY COMPARISON · NSE
EVONILE vs GUFICBIO
Compare business size, valuation, growth and ownership. Higher or lower does not automatically mean better.
GUFICBIO · Pharmaceuticals
Gufic Biosciences Limited
- Company snapshot
- 2026-11-05
- Latest available quarter
- 2026-06-30Consolidated
- Ownership quarter
- 2026-09-30
Side by side
Choose a metric group. Tap a metric’s explanation button for context.
19 metrics shown
| Metric | EVONILE | GUFICBIO |
|---|---|---|
| Price | ₹1,716.5 | ₹434.45 |
| Market cap | ₹4,288 cr | ₹4,278 cr |
| P/E | — | 59.3 |
| P/B | 5.5 | — |
| ROE | 11.6% | 10.1% |
| ROCE | 11.8% | 15.3% |
| Debt / equity | 0 | 0.61 |
| Operating margin | 12.1% | 13.6% |
| Dividend yield | 1.44% | 0.02% |
| Sales growth, 3 years (yearly) | -2.2% | 11.0% |
| Profit growth, 3 years (yearly) | -3.4% | -6.9% |
| 1-year return | 0.4% | 32.1% |
| Revenue, last 12 months | ₹336 cr | ₹981 cr |
| Net profit, last 12 months | ₹-4 cr | ₹73 cr |
| Latest available quarter | — | Jun 2026 |
| Quarter net profit | — | ₹22 cr |
| Quarter profit vs a year earlier | — | +70.7% |
| Promoter holding | — | 72.50% |
| Health check | Weak (2/10) | Average (5.7/10) |